“…Both physiological and behavioral research suggest that a-MSH influences mood and emotion. Administration of a-MSH to humans affects cardiac and vascular processes (Aldinger, Hawley, Schally, & Kastin, 1973;Kadowitz, Chap-nick, & Kastin, 1976;Kastin el al.. 1975;Sandman et al, 1977), enhances vagal tone (LaHoste, Olson, Kastin & Olson, 1980), and reduces reports of "state anxiety" (Miller et al, 1974;Sandman, George, Nolan, Van Riezen, & Kastin, 1975). Studies with both humans and animals reveal that a-MSH, which is released in response to a variety of stressors (Dunn, Kastin, Camllo, & Schally, 1972;Kastin et al, 1973;Sandman, Kastin, Schally, Kendall, & Miller, 1973), reduces responsiveness to pain and creates a behavioral profile resembling that produced by the opioid beta-endorphin (P-END) (Walker, Akil, & Watson, 1980).…”